Menu
Create an Account
Log in
Home
Activities
Courses and Conferences
HIV In-Person and Virtual Courses
Earn CME From On-Demand Webcasts
The 2022 Ryan White HIV/AIDS Program CLINICAL CONFERENCE
Conference on Retroviruses and Opportunistic Infections
About IAS–USA Courses
Webinars
Upcoming Webinars
2022 On-Demand Webinars
Earn CME From On-Demand Webinars
About Webinars
COVID-19 Dialogue Series
Upcoming Dialogues
On-Demand Dialogues
Topics in Antiviral Medicine
Current Issues
Previous Issues
TAM
Policies and Practices
Resources
Guidelines
HIV Drug Resistance Mutations
Podcasts
On-Demand Webcasts
Slides
Research Collaboration
Useful Resources for COVID-19 Information and Guidance
Practice Question of the Week
Fellow/Student Resources
Other Resources
About
Mission
IAS–USA Scientific Leadership Board
IAS–USA Governance
Core Faculty
Staff
CME
Funding Information
Careers
Donate
Website Policies
FAQs
Contact
Topics in Antiviral Medicine
™
October/November 2021
Volume 29, Issue 4
Download here
, or select individual articles
Claim CME
Perspective
Primary Care Concerns for the Aging Population With HIV
Steven C. Johnson, MD
Invited Reviews
Challenges and Opportunities for Preexposure Prophylaxis
Mary Catherine Cambou, MD, Raphael J. Landovitz, MD, MSc
HIV and Cardiovascular Disease: From Insights to Interventions
Matthew J. Feinstein, MD, MSc
Topics in Antiviral Medicine™
Current Issues
Previous Issues
TAM
Policies and Practices
TAM
Author and Contributor Guidelines
Topics in Antiviral Medicine
Editorial Board
Home
Activities
Courses and Conferences
HIV In-Person and Virtual Courses
Earn CME From On-Demand Webcasts
The 2022 Ryan White HIV/AIDS Program CLINICAL CONFERENCE
Conference on Retroviruses and Opportunistic Infections
About IAS–USA Courses
Webinars
Upcoming Webinars
2022 On-Demand Webinars
Earn CME From On-Demand Webinars
About Webinars
COVID-19 Dialogue Series
Upcoming Dialogues
On-Demand Dialogues
Topics in Antiviral Medicine
Current Issues
Previous Issues
TAM
Policies and Practices
Resources
Guidelines
HIV Drug Resistance Mutations
Podcasts
On-Demand Webcasts
Slides
Research Collaboration
Useful Resources for COVID-19 Information and Guidance
Practice Question of the Week
Fellow/Student Resources
Other Resources
About
Mission
IAS–USA Scientific Leadership Board
IAS–USA Governance
Core Faculty
Staff
CME
Funding Information
Careers
Donate
Website Policies
FAQs
Contact
Practice Question of the Week
May 23, 2022: Treating Depression in People With HIV
A 38-year-old man diagnosed with HIV comes to the office expressing passive suicidal ideation. During the past 6 weeks, he has experienced fatigue, loss of interest in usual activities, a 7-kg (15-lb) weight loss, and insomnia. He is diagnosed with a major depressive episode. Which of the following is NOT true regarding his depression treatment?
A. Beginning a low dose of antidepressant reduces the risk of adverse effects
B. Escalating the dose of an antidepressant medication should be avoided
C. Accepting treatment with antidepressants is associated with greater adherence to antiretroviral medications
D. More than one antidepressant trial may be needed to achieve remission from depression
Watch Webcast
View Related Resources
Leave Feedback
Subscribe
CLOSE